Suchergebnisse - "Neuroblastoma"

PubPharm (11.588)

21

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tipifarnib in Patients With Tumors Harboring HRAS Genomic Alterations

enthalten in: ClinicalTrials.gov | 2024

22

SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours : SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

enthalten in: ClinicalTrials.gov | 2024

23

Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers

enthalten in: Cell chemical biology | 2024

von Stokes, M. | Vasciaveo, A. | Small, J. | +9

24

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma : A Pilot Induction Regimen Incorporating Chimeric 14.18 Antibody (ch14.18, Dinutuximab) (NSC# 764038) and Sargramostim (GM-CSF) for the Treatment of Newly Diagnosed High-Risk Neuroblastoma

enthalten in: ClinicalTrials.gov | 2024

25

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma : A Phase 1b/2 Study of Abemaciclib in Combination With Irinotecan and Temozolomide (Part A) and Abemaciclib in Combination With Temozolomide (Part B) in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors and Abemaciclib in Combination With Dinutuximab, GM-CSF, Irinotecan, and Temozolomide in Pediatric and Young Adult Patients With Relapsed/Refractory Neuroblastoma (Part C)

enthalten in: ClinicalTrials.gov | 2024

26

HN1 is a novel dedifferentiation factor involved in regulating the cell cycle and microtubules in SH-SY5Y neuroblastoma cells

enthalten in: Journal of cellular biochemistry | 2024

von Özar, T. | Javed, A. | Özduman, G. | +1

27

Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis

enthalten in: International journal of molecular sciences | 2024

von Boccarelli, A. | Del Buono, N. | Esposito, F.

28

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma : Neuroblastoma Biology Studies

enthalten in: ClinicalTrials.gov | 2024

29

Differential RNA Expression Between Metastatic and Primary Neuroblastoma Cells

enthalten in: The Journal of surgical research | 2024

von Lee, W. | Asuelime, G. | Asuelime-Smith, M. | +2

30

CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma

enthalten in: Cancer letters | 2024

von Zhuo, R. | Zhang, Z. | Chen, Y. | +25